COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Maine patients with a documented clinical need may be eligible for compounded tirzepatide.
Maine’s rural northern and western regions have limited local pharmacy access. Compounding Finder helps Maine residents connect with licensed pharmacies that ship throughout the state.
Yes. The Maine Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.